Biomarker Technologies uses Chimeric RNA Sequencing to Identify Genomic Variations

Biomarker Technologies (BMKGene) is leveraging chimeric RNA sequencing, a technique designed to uncover hidden genomic events. This advanced method identifies structural variations within the genome, pinpointing cancer drivers and trait-associated gene fusions that often go undetected by traditional gene expression analysis.

While standard RNA sequencing typically focuses on quantifying gene expression levels, chimeric RNAs represent a more complex layer of genetic information. These molecules are formed when sequences from two distinct genes become joined into a single RNA transcript. Once considered rare anomalies, chimeric RNAs are now recognized as significant regulators in development, disease, and evolution. BMKGene states that their application of chimeric RNA detection serves as a powerful tool for identifying genomic rearrangements, discovering disease biomarkers, and understanding the molecular basis of complex phenotypes across various biological systems.

The technology relies on high-quality RNA sequencing data coupled with sophisticated bioinformatics algorithms. It detects RNA molecules that span the boundaries of two different genes, resulting from mechanisms such as chromosomal translocations, large genomic rearrangements, transcriptional read-through, or trans-splicing. This allows for the identification of actively expressed structural variants that may be associated with diseases, including cancer.

BMKGene highlights the critical role of chimeric RNA detection in cancer research. Many cancers are driven by gene fusions arising from chromosomal rearrangements. Chimeric RNA sequencing offers a direct way to detect these fusions at the RNA level, aiding in the identification of oncogenic drivers and potentially informing targeted therapeutic strategies.

This approach enables researchers to connect genomic rearrangements with their downstream transcriptional consequences. When combined with other genomic analyses, such as whole-genome sequencing, chimeric RNA analysis provides strong evidence linking genetic alterations to their functional effects, offering deeper insights into disease mechanisms and opening avenues for diagnostics and treatment development.